Protein corona formation on magnetite nanoparticles: Effects of culture medium composition, and its consequences on superparamagnetic nanoparticle cytotoxicity

Journal of Biomedical Nanotechnology

Volumn 11, Issue 5, 2015, Pages 828-840

  Mbeh, D A ^a   Javanbakht, T ^a   Tabet, L ^b   Merhi, Y ^c   Maghni, K ^b   Sacher, E ^a   Yahia, L H ^a  

^a ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Interference; Protein corona; Serum; Superparamagnetic iron oxide nanoparticles (SPIONs); Surface characterization

Indexed keywords

ASSAYS; CELL CULTURE; DESORPTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; IRON OXIDES; MAGNETITE NANOPARTICLES; SECONDARY ION MASS SPECTROMETRY; SUPERPARAMAGNETISM; TOPOGRAPHY; WAVE INTERFERENCE;

MATRIX ASSISTED LASER DESORPTION/IONIZATION; PHYSICOCHEMICAL PROPERTY; POTENTIAL MEASUREMENTS; PROTEIN CORONAS; SERUM; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC NANOPARTICLES; SURFACE CHARACTERIZATION;

PROTEINS;

PROTEIN; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; CULTURE MEDIUM; CYTOTOXIN; DEXTRAN; MAGNETITE NANOPARTICLE; PLASMA PROTEIN; PROTEIN AGGREGATE; SUPERPARAMAGNETIC IRON OXIDE;

ADSORPTION; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; HYDRODYNAMICS; IN VITRO STUDY; INFRARED SPECTROSCOPY; ISOELECTRIC POINT; LIGHT SCATTERING; MAGNETIC FIELD; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MTT ASSAY; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CORONA FORMATION; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN MODIFICATION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; SURFACE PROPERTY; TUMOR CELL CULTURE;

ADSORPTION; BLOOD PROTEINS; CELL SURVIVAL; CULTURE MEDIA; CYTOTOXINS; DEXTRANS; HUMANS; MAGNETITE NANOPARTICLES; PROTEIN AGGREGATES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES; TUMOR CELLS, CULTURED;

EID: 84918557509     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2015.2000     Document Type: Article

References (74)

1. M. Auffan, J. Y. Bottero, C. Chaneac, and J. Rose, Inorganic manufactured nanoparticles: How their physicochemical properties influence their biological effects in aqueous environments. Nanomedicine-Nanotechnology, Biology, and Medicine 5, 999 (2010).
2. E. Casals, E. Gonzalez, and V. F. Puntes, Reactivity of inorganic nanoparticles in biological environments: Insights into nanotoxicity mechanisms. Journal of Physics D-Applied Physics 45, 443001 (2012).
3. C. K. Chiang, W. T. Chen, and H. T. Chang, Nanoparticle-based mass spectrometry for the analysis of biomolecules. Chem. Soc. Rev. 40, 1269 (2011).
4. M. A. Dobrovolskaia, A. K. Patri, J. Zheng, J. D. Clogston, N. Ayub, P. Aggarwal, B. W. Neun, J. B. Hall, and S. E. Mcneil, Interaction of colloidal gold nanoparticles with human blood: Effects on particle size and analysis of plasma protein binding profiles. Nanomedicine: Nanotechnology, Biology, and Medicine 5, 106 (2009).
5. J. E. Gagner, S. Shrivastava, X. Qian, J. S. Dordick, and R. W. Siegel, Engineering nanomaterials for biomedical applications requires understanding the nano-bio interface: A perspective. Journal of Physical Chemistry Letters 3, 3149 (2012).
6. A. Garland, L. Shen, and X. Y. Zhu, Mobile precursor mediated protein adsorption on solid surfaces. Prog. Surf. Sci. 87, 1 (2012).
7. J. K. Jiang, G. Oberdorster, and P. Biswas, Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J. Nanopart. Res. 11, 77 (2009).
8. P. Koegler, A. Clayton, H. Thissen, G. N. Santos, and P. Kingshott, The influence of nanostructured materials on biointerfacial interactions. Advanced Drug Delivery Reviews 64, 1820 (2012).
9. R. Levy, U. Shaheen, Y. Cesbron, and V. See, Gold nanoparticles delivery in mammalian live cells: A critical review. Nano Reviews 1, 4889 (2010).
10. I. Lynch, T. CedervalL, M. Lundqvist, C. Cabaleiro-Lago, S. Linse, and K. A. Dawson, The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci. 134-135, 167 (2007).
11. I. Lynch and K. A. Dawson, Protein-nanoparticle interactions. Nano Today 3, 40 (2008).
12. M. Mahmoudi, I. Lynch, M. R. Ejtehadi, M. P. Monopoli, F. B. Bombelli, and S. Laurent, Protein-nanoparticle interactions: Opportunities and challenges. Chem. Rev. 111, 5610 (2011).
13. D. F. Moyano and V. M. Rotello, Nano meets biology: Structure and function at the nanoparticle interface. Langmuir 27, 10376 (2011).
14. A. E. Nel, L. Madler, D. VelegoL, T. Xia, E. M. Hoek, P. Somasundaran, F. Klaessig, V. Castranova, and M. Thompson, Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8, 543 (2009).
15. A. Pelaz, G. Charron, C. Pfeiffer, Y. Zhao, J. M. DE LA Fuente, X. J. Liang, W. J. Parak, and P. Del Pino, Interfacing engineered nanoparticles with biological systems: Anticipating adverse nano-bio interactions. Small 9, 1573 (2013).
16. M. Rabe, D. Verdes, and S. Seeger, Understanding protein adsorption phenomena at solid surfaces. Adv. Colloid Interface Sci. 162, 87 (2011).
17. S. Federici, G. Oliviero, D. Maiolo, L. E. Depero, I. Colombo, and P. Bergese, On the thermodynamics of biomolecule surface transformations. Adv. Colloid Interface Sci. 375, 1 (2012).
18. S. Rana, Y. C. Yeh, and V. M. Rotello, Engineering the nanoparticleprotein interface: Applications and possibilities. Abbreviations Journal Names 14, 828 (2010).
19. A. A. Shemetov, I. Nabiev, and A. Sukhanova, Molecular interaction of proteins and peptides with nanoparticles. ACS Nano 6, 4585 (2012).
20. A. D. Walkey and W. C. Chan, Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 41, 2780 (2012).
21. N. Welsch, Y. Lu, J. Dzubiella, and M. Ballauff, Adsorption of proteins to functional polymeric nanoparticles. Polymer 54, 2835 (2013).
22. S. T. Yang, Y. Liu, Y. W. Wang, and A. Cao, Biosafety and bioapplication of nanomaterials by designing protein-nanoparticle interactions. Small 9, 1635 (2013).
23. A. Pelaz, G. Charron, C. Pfeiffer, Y. Zhao, J. M. DE LA Fuente, X. J. Liang, W. J. Parak, and P. DEl pino, Interfacing engineered nanoparticles with biological systems: Anticipating adverse nano-bio interactions. Small 9, 1573 (2013).
24. R. Franca, X. F. Zhang, T. Veres, L. Yahia, and E. Sacher, Core-shell nanoparticles as prodrugs: Possible cytotoxicological and biomedical impacts of batch-to-batch inconsistencies. J. Colloid Interface Sci. 389, 292 (2013).
25. K. Natte, J. F. Friedrich, S. Wohlrab, J. Lutzki, R. von Klitzing, W. Österle, and G. Orts-Gil, Impact of polymer shell on the formation and time evolution of nanoparticle-protein corona. Colloids and Surfaces B: Biointerfaces 104, 213 26. V. N. Maiorov and G. M. Crippen, Contact potential that recognizes the correct folding of globular proteins. J. Mol. Biol. 227, 876 (1992).
26. H. P. Erickson, Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy. Biol. Proc. Online 11, 32 (2009).
27. E. A. Vogler, Protein adsorption in three dimensions. Biomaterials 33, 1201 (2012).
28. T. Cedervall, I. Lynch, S. Lindman, T. Berggard, E. Thulin, H. Nilsson, K. A. Dawson, and S. Linse, Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proceedings of the National Academy of Sciences of the United States of America 104, 2050 (2007).
29. X. Jiang, S. Weise, M. Hafner, C. Rocker, F. Zhang, W. J. Parak, and G. U. Nienhaus, Quantitative analysis of the protein corona on fept nanoparticles formed by transferrin binding. Journal of the Royal Society, Interface/The Royal Society 7, s5 (2010).
30. W. J. Stark, Nanoparticles in biological systems. Angewandte Chemie 50, 1242 (2011).
31. I. Lynch, A. Salvati, and k. A. Dawson, Protein-nanoparticle interactions: What does the cell see? Nat. Nanotechnol. 4, 546 (2009).
32. D. Walczyk, F. B. Bombelli, M. P. Monopoli, I. Lynch, and K. A. Dawson, What the cell "sees" in bionanoscience. J. Am. Chem. Soc. 132, 5761 (2010).
33. A. Kroll, M. H. Pillukat, D. Hahn, and J. Schnekenburger, Interference of engineered nanoparticles with in vitro toxicity assays. Arch. Toxicol. 86, 1123 (2012).
34. M. Pozzolini, S. Scarf, U. Benatti, and M. Giovine, Interference in MTT cell viability assay in activated macrophage cell line. Anal. Biochem. 313, 338 (2003).
35. N. A. Monteiro-Riviere, A. O. Inman, and L. W. Zhang, Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol. Appl. Pharmacol. 234, 222 (2009).
36. S. Poulin, R. Franca, L. Moreau-Belanger, and E. Sacher, Confirmation of X-ray photoelectron spectroscopy peak attributions of nanoparticulate iron oxides, using symmetric peak component line shapes. Journal of Physical Chemistry C 114, 10711 (2010).
37. S. M. Hussain, K. L. Hess, J. M. Gearhart, K. T. Geiss, and J. J. Schlager, In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicology in Vitro 19, 975 (2005).
38. Y. Ge, Y. Zhang, J. Xia, M. Ma, S. He, F. Nie, and N. Gu, Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. Colloids and Surfaces B, Biointerfaces 73, 294 (2009).
39. V. Dousset, C. Delalande, L. Ballarino, B. Quesson, D. Seilhan, M. Coussemacq, E. Thiaudiere, B. Brochet, P. CanionI, and J. M. Caille, In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magnetic Resonance in Medicine 41, 329 (1999).
40. R. Wottrich, S. Diabate, and H. F. Krug, Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. International Journal of Hygiene and Environmental Health 207, 353 (2004).
41. A. Simon-Deckers, B. Gouget, M. Mayne-L'hermite, N. Herlin- Boime, C. Reynaud, and M. Carriere, In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in a549 human pneumocytes. Toxicology 253, 137 (2008).
42. O. F. Karatas, E. Sezgin, O. Aydin, and M. Culha, Interaction of gold nanoparticles with mitochondria. Colloids and Surfaces B, Biointerfaces 71, 315 (2009).
43. M. M. Bradford, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72, 248 (1976).
44. Z. K. Xu, R. Q. Kou, Z. M. Liu, F. Q. Nie, and Y. Y. Xu, Incorporating alpha-allyl glucoside into polyacrylonitrile by water-phase precipitation copolymerization to reduce protein adsorption and cell adhesion. Macromolecules 36, 2441 (2003).
45. K. Rezwan, L. P. Meier, M. Rezwan, J. Voros, M. Textor, and L. J. Gauckler, Bovine serum albumin adsorption onto colloidal al2o3 particles: A new model based on zeta potential and uv-vis measurements. Langmuir 20, 10055 (2004).
46. R. Barbucci, A. Magnani, A. Chiumiento, D. Pasqui, I. Cangioli, and S. Lamponi, Fibroblast cell behavior on bound and adsorbed fibronectin onto hyaluronan and sulfated hyaluronan substrates. Biomacromolecules 6, 638 (2005).
47. M. Mahmoudi, I. Lynch, M. R. Ejtehadi, M. P. Monopoli, F. B. Bombelli, and S. Laurent, Protein-nanoparticle interactions: Opportunities and challenges. Chem. Rev. 111, 5610 (2011).
48. P. Kingshott, H. A. W. St John, R. C. Chatelier, and H. J. Griesser, Matrix-assisted laser desorption ionization mass spectrometry detection of proteins adsorbed in vivo onto contact lenses. Journal of Biomedical Materials Research 49, 36 (2000).
49. H. J. Griesser, P. Kingshott, S. L. Mcarthur, K. M. Mclean, G. R. Kinsel, and R. B. Timmons, Surface-maldi mass spectrometry in biomaterials research. Biomaterials 25, 4861 (2004).
50. A. R. Boyd, G. A. Burke, H. Duffy, M. Holmberg, C. O. Kane, B. J. Meenan, and P. Kingshott, Sputter deposited bioceramic coatings: Surface characterisation and initial protein adsorption studies using surface-maldi-ms. Journal of Materials Science-Materials in Medicine 22, 71 (2011).
51. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 55 (1983).
52. A. K. Chiang, W. T. Chen, and H. T. Chang, Nanoparticle-based mass spectrometry for the analysis of biomolecules. Chem. Soc. Rev. 40, 1269 (2011).
53. K. Y. Wang, S. A. Chuang, P. C. Lin, L. S. Huang, S. H. Chen, S. Ouarda, W. H. Pan, P. Y. Lee, C. C. Lin, and Y. J. Chen, Multiplexed immunoassay: Quantitation and profiling of serum biomarkers using magnetic nanoprobes and MALDI-TOF MS. Analytical Chemistry 80, 6159 (2008).
54. M. Kosmulski, pH-dependent surface charging and points of zero charge. IV. Update and new approach. J. Colloid Interface Sci. 337, 439 (2009).
55. Z. Ganim, H. S. Chung, A. W. Smith, L. P. Deflores, K. C. Jones, and A. Tokmakoff, Amide i two-dimensional infrared spectroscopy of proteins. Acc. Chem. Res. 41, 432 (2008).
56. A. Barth and C. Zscherp, what vibrations tell us about proteins. Quarterly Reviews of Biophysics 35, 369 (2002).
57. S. Cavalu and V. Simon, Proteins adsorption to orthopaedic biomaterials: Vibrational spectroscopy evidence. Journal of Optoelectronics and Advanced Materials 9, 3297 (2007).
58. W. J. Qian, J. M. Jacobs, D. G. Camp, M. E. Monroe, R. J. Moore, M. A. Gritsenko, S. E. Calvano, S. F. Lowry, W. Xiao, L. L. Moldawer, R. W. Davis, R. G. Tompkins, and R. D. Smith, Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 5, 572 (2005).
59. L. Vroman, A. L. Adams, G. C. Fisher, and P. C. Munoz, Interaction of high molecular weight kininogen, Factor XII and fibrinogen in plasma at interfaces. Blood 55, 156 (1980).
60. L. Vroman and A. L. Adams, Adsorption of proteins out of plasma and solutions in narrow spaces. J. Colloid Interface Sci. 111, 391 (1986).
61. J. D. Andrade and V. Hlady, Protein adsorption and materials biocompatibility: A tutorial review and suggested hypotheses. Adv. Polym. Sci. 79, 1 (1986).
62. J. D. Andrade and V. Hlady, Vroman effects, techniques and philosophies. J. Biomater. Sci. Polym. 2, 161 (1991).
63. I. Lynch and K. A. Dawson, Protein-nanoparticle interactions. Nano Today 3, 40 (2008).
64. C. Schulze, A. Kroll C. M. Lehr, U. F. Schafer, K. Becker, J. Schnekenburger, C. S. Isfort, R. Landsiedel, and W. Wohlleben, Not ready to use-overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2, 51 (2008).
65. Z. P. Chen, R. Z. Xu, Y. Zhang, and N. Gu, Effects of proteins from culture medium on surface property of silanes-functionalized magnetic nanoparticles. Nanoscale Research Letters 4, 204 (2009).
66. G. Maiorano, S. Sabella, B. Sorce, V. Brunetti, M. A. Malvindi, R. Cingolani, and P. P. Pompa, Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. Acs Nano 4, 7481 (2010).
67. M. Horie, K. Nishio, K. Fujita, S. Endoh, A. Miyauchi, Y. Saito, H. Iwahashi, K. Yamamoto, H. Murayama, H. Nakano, N. Nanashima, E. Niki, and Y. Yoshida, Protein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cells. Chem. Res. Toxicol. 22, 543 (2009).
68. H. L. Karlsson, P. Cronholm, J. Gustafsson, and L. Moller, Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes. Chemical Research in Toxicology, 21, 1726 (2008).
69. P. Chairuangkitti, S. Lawanprasert, S. Roytrakul, S. Aueviriyavit, D. Phummiratch, K. Kulthong, P. Chanvorachote, and R. Maniratanachote, Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicology in Vitro: An International Journal Published in Association with BIBRA 27, 330 (2013).
70. H. Kim, S. C. Yoon, T. Y. Lee, and D. Jeong, Discriminative cytotoxicity assessment based on various cellular damages. Toxicology Letters 184, 13 (2009).
71. W. Liu, J. Rose, S. Plantevin, M. Auffan, J. Y. Bottero, and C. Vidaud, Protein corona formation for nanomaterials and proteins of a similar size: Hard or soft corona? Nanoscale 5, 1658 (2013).
72. M. Safi, H. Sarrouj, O. Sandre, N. Mignet, and J. F. Berret, Interactions between sub-10-nm iron and cerium oxide nanoparticles and 3T3 fibroblasts: The role of the coating and aggregation state. Nanotechnology 21, 145103 (2010).
73. J. Geys, B. Nemery, and P. H. Hoet, Assay conditions can influence the outcome of cytotoxicity tests of nanomaterials: Better assay characterization is needed to compare studies. Toxicology in Vitro 24, 620 (2010).
74. Y. Chang, S. T. Yang, J. H. Liu, E. Dong, Y. Wang, A. Cao, Y. Liu, and H. Wang, In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicology Letters 200, 201 (2011).